CN105963429A - 快速消肿的外用药膏
文章推薦指數: 80 %
本发明提供一种快速消肿的外用药膏,由按重量份计的下列原料制成:蒲公英20~30重量份,大青叶1~5重量份,瓜子金5~15重量份,半边莲10~20重量份,茶油100~200重量 ...
CN105963429A-快速消肿的外用药膏
-GooglePatents
快速消肿的外用药膏
DownloadPDF
Info
Publicationnumber
CN105963429A
CN105963429A
CN201610610865.9A
CN201610610865A
CN105963429A
CN105963429A
CN105963429A
CN105963429A
CN201610610865A
CN201610610865A
CN201610610865A
CN105963429A
CN105963429A
CN105963429A
Authority
CN
China
Priorartkeywords
weight
external
unguent
application
parts
Priorartdate
2016-07-29
Legalstatus(Thelegalstatusisanassumptionandisnotalegalconclusion.Googlehasnotperformedalegalanalysisandmakesnorepresentationastotheaccuracyofthestatuslisted.)
Pending
Applicationnumber
CN201610610865.9A
Otherlanguages
English(en)
Inventor
万小耀
OriginalAssignee
万小耀
Prioritydate(Theprioritydateisanassumptionandisnotalegalconclusion.Googlehasnotperformedalegalanalysisandmakesnorepresentationastotheaccuracyofthedatelisted.)
2016-07-29
Filingdate
2016-07-29
Publicationdate
2016-09-28
2016-07-29
Applicationfiledby万小耀
filed
Critical
万小耀
2016-07-29
PrioritytoCN201610610865.9A
priority
Critical
patent/CN105963429A/zh
2016-09-28
PublicationofCN105963429A
publication
Critical
patent/CN105963429A/zh
Links
Espacenet
GlobalDossier
Discuss
239000002674
ointment
Substances
0.000
title
claims
abstract
description
13
230000002522
swelling
Effects
0.000
title
abstract
description
4
239000002994
rawmaterial
Substances
0.000
claims
description
4
QAOWNCQODCNURD-UHFFFAOYSA-N
Sulfuricacid
Chemicalcompound
data:image/svg+xml;base64,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
data:image/svg+xml;base64,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
OS(O)(=O)=O
QAOWNCQODCNURD-UHFFFAOYSA-N
0.000
claims
description
3
239000007766
ceraflava
Substances
0.000
claims
description
3
241000146384
Glaux
Species
0.000
abstract
1
235000013871
beewax
Nutrition
0.000
abstract
1
239000010495
camelliaoil
Substances
0.000
abstract
1
235000008216
herbs
Nutrition
0.000
abstract
1
208000002193
Pain
Diseases
0.000
description
4
230000000694
effects
Effects
0.000
description
4
206010003402
Arthropodsting
Diseases
0.000
description
3
206010015150
Erythema
Diseases
0.000
description
2
239000003814
drug
Substances
0.000
description
2
235000012907
honey
Nutrition
0.000
description
2
239000012567
medicalmaterial
Substances
0.000
description
2
208000004998
AbdominalPain
Diseases
0.000
description
1
208000007502
Anemia
Diseases
0.000
description
1
206010012735
Diarrhoea
Diseases
0.000
description
1
206010013954
Dysphoria
Diseases
0.000
description
1
206010015866
Extravasation
Diseases
0.000
description
1
206010016322
Feelingabnormal
Diseases
0.000
description
1
206010019233
Headache
Diseases
0.000
description
1
241000238631
Hexapoda
Species
0.000
description
1
102000018358
Immunoglobulins
Humangenes
0.000
description
1
108060003951
Immunoglobulins
Proteins
0.000
description
1
210000002381
Plasma
Anatomy
0.000
description
1
208000003251
Pruritus
Diseases
0.000
description
1
230000036772
bloodpressure
Effects
0.000
description
1
238000006243
chemicalreaction
Methods
0.000
description
1
201000008286
diarrhea
Diseases
0.000
description
1
238000003379
eliminationreaction
Methods
0.000
description
1
230000036251
extravasation
Effects
0.000
description
1
231100000869
headache
Toxicity
0.000
description
1
235000013402
healthfood
Nutrition
0.000
description
1
238000010438
heattreatment
Methods
0.000
description
1
239000000463
material
Substances
0.000
description
1
230000035699
permeability
Effects
0.000
description
1
238000002360
preparationmethod
Methods
0.000
description
1
230000002792
vascular
Effects
0.000
description
1
230000024883
vasodilation
Effects
0.000
description
1
210000004916
vomit
Anatomy
0.000
description
1
Classifications
A—HUMANNECESSITIES
A61—MEDICALORVETERINARYSCIENCE;HYGIENE
A61K—PREPARATIONSFORMEDICAL,DENTAL,ORTOILETPURPOSES
A61K35/00—Medicinalpreparationscontainingmaterialsorreactionproductsthereofwithundeterminedconstitution
A61K35/56—Materialsfromanimalsotherthanmammals
A61K35/63—Arthropods
A61K35/64—Insects,e.g.bees,waspsorfleas
A61K35/644—Beeswax;Propolis;Royaljelly;Honey
A—HUMANNECESSITIES
A61—MEDICALORVETERINARYSCIENCE;HYGIENE
A61K—PREPARATIONSFORMEDICAL,DENTAL,ORTOILETPURPOSES
A61K36/00—Medicinalpreparationsofundeterminedconstitutioncontainingmaterialfromalgae,lichens,fungiorplants,orderivativesthereof,e.g.traditionalherbalmedicines
A61K36/18—Magnoliophyta(angiosperms)
A61K36/185—Magnoliopsida(dicotyledons)
A61K36/19—Acanthaceae(Acanthusfamily)
A61K36/195—Strobilanthes
A—HUMANNECESSITIES
A61—MEDICALORVETERINARYSCIENCE;HYGIENE
A61K—PREPARATIONSFORMEDICAL,DENTAL,ORTOILETPURPOSES
A61K36/00—Medicinalpreparationsofundeterminedconstitutioncontainingmaterialfromalgae,lichens,fungiorplants,orderivativesthereof,e.g.traditionalherbalmedicines
A61K36/18—Magnoliophyta(angiosperms)
A61K36/185—Magnoliopsida(dicotyledons)
A61K36/28—AsteraceaeorCompositae(AsterorSunflowerfamily),e.g.chamomile,feverfew,yarroworechinacea
A61K36/288—Taraxacum(dandelion)
A—HUMANNECESSITIES
A61—MEDICALORVETERINARYSCIENCE;HYGIENE
A61K—PREPARATIONSFORMEDICAL,DENTAL,ORTOILETPURPOSES
A61K36/00—Medicinalpreparationsofundeterminedconstitutioncontainingmaterialfromalgae,lichens,fungiorplants,orderivativesthereof,e.g.traditionalherbalmedicines
A61K36/18—Magnoliophyta(angiosperms)
A61K36/185—Magnoliopsida(dicotyledons)
A61K36/31—BrassicaceaeorCruciferae(Mustardfamily),e.g.broccoli,cabbageorkohlrabi
A61K36/315—Isatis,e.g.Dyer'swoad
A—HUMANNECESSITIES
A61—MEDICALORVETERINARYSCIENCE;HYGIENE
A61K—PREPARATIONSFORMEDICAL,DENTAL,ORTOILETPURPOSES
A61K36/00—Medicinalpreparationsofundeterminedconstitutioncontainingmaterialfromalgae,lichens,fungiorplants,orderivativesthereof,e.g.traditionalherbalmedicines
A61K36/18—Magnoliophyta(angiosperms)
A61K36/185—Magnoliopsida(dicotyledons)
A61K36/34—Campanulaceae(Bellflowerfamily)
A—HUMANNECESSITIES
A61—MEDICALORVETERINARYSCIENCE;HYGIENE
A61K—PREPARATIONSFORMEDICAL,DENTAL,ORTOILETPURPOSES
A61K36/00—Medicinalpreparationsofundeterminedconstitutioncontainingmaterialfromalgae,lichens,fungiorplants,orderivativesthereof,e.g.traditionalherbalmedicines
A61K36/18—Magnoliophyta(angiosperms)
A61K36/185—Magnoliopsida(dicotyledons)
A61K36/69—Polygalaceae(Milkwortfamily)
A—HUMANNECESSITIES
A61—MEDICALORVETERINARYSCIENCE;HYGIENE
A61K—PREPARATIONSFORMEDICAL,DENTAL,ORTOILETPURPOSES
A61K36/00—Medicinalpreparationsofundeterminedconstitutioncontainingmaterialfromalgae,lichens,fungiorplants,orderivativesthereof,e.g.traditionalherbalmedicines
A61K36/18—Magnoliophyta(angiosperms)
A61K36/185—Magnoliopsida(dicotyledons)
A61K36/70—Polygonaceae(Buckwheatfamily),e.g.spineflowerordock
A61K36/704—Polygonum,e.g.knotweed
A—HUMANNECESSITIES
A61—MEDICALORVETERINARYSCIENCE;HYGIENE
A61K—PREPARATIONSFORMEDICAL,DENTAL,ORTOILETPURPOSES
A61K36/00—Medicinalpreparationsofundeterminedconstitutioncontainingmaterialfromalgae,lichens,fungiorplants,orderivativesthereof,e.g.traditionalherbalmedicines
A61K36/18—Magnoliophyta(angiosperms)
A61K36/185—Magnoliopsida(dicotyledons)
A61K36/82—Theaceae(Teafamily),e.g.camellia
A—HUMANNECESSITIES
A61—MEDICALORVETERINARYSCIENCE;HYGIENE
A61K—PREPARATIONSFORMEDICAL,DENTAL,ORTOILETPURPOSES
A61K36/00—Medicinalpreparationsofundeterminedconstitutioncontainingmaterialfromalgae,lichens,fungiorplants,orderivativesthereof,e.g.traditionalherbalmedicines
A61K36/18—Magnoliophyta(angiosperms)
A61K36/185—Magnoliopsida(dicotyledons)
A61K36/85—Verbenaceae(Verbenafamily)
A61K36/855—Clerodendrum,e.g.glorybower
A—HUMANNECESSITIES
A61—MEDICALORVETERINARYSCIENCE;HYGIENE
A61K—PREPARATIONSFORMEDICAL,DENTAL,ORTOILETPURPOSES
A61K9/00—Medicinalpreparationscharacterisedbyspecialphysicalform
A61K9/0012—Galenicalformscharacterisedbythesiteofapplication
A61K9/0014—Skin,i.e.galenicalaspectsoftopicalcompositions
A—HUMANNECESSITIES
A61—MEDICALORVETERINARYSCIENCE;HYGIENE
A61K—PREPARATIONSFORMEDICAL,DENTAL,ORTOILETPURPOSES
A61K9/00—Medicinalpreparationscharacterisedbyspecialphysicalform
A61K9/06—Ointments;Basestherefor;Othersemi-solidforms,e.g.creams,sticks,gels
Abstract
本发明提供一种快速消肿的外用药膏,由按重量份计的下列原料制成:蒲公英20~30重量份,大青叶1~5重量份,瓜子金5~15重量份,半边莲10~20重量份,茶油100~200重量份,蜂蜡30~50重量份,本发明具有以下有益效果:能够经济、有效、方便使用的快速消肿。
Description
快速消肿的外用药膏
技术领域
[0001]
本发明属于中药制剂技术领域,尤其涉及一种快速消肿的外用药膏。
[0002]
背景技术
[0003]对健康的追求以及对自然的亲近,人们户外运动愈加频繁、涉及的地方越来越广泛。
另一方面人民对健康食品的需求的增加,其中有包括蜂蜜;要增加蜂蜜产量则需要增加蜜蜂,然而蜜蜂的活动面积也就增加。
热爱户外的人们活动面积和蜜蜂的采蜜面积产生重合,人民被蜜蜂蜇伤不可以避免。
[0004]蜜蜂蛰伤,其毒刺留于刺伤处,蜂毒呈酸性,蜂毒进入人体后,可与体内的免疫球蛋白结合,产生一系列反应,从而引起血管扩张,血管通透性增加,血浆外渗,血压下降。
蛰伤局部会产生红肿、疼痛、瘙痒等症状,严重的可引起发热、头痛、呕吐、腹痛、腹泻、烦躁不安等症状。
[0005]蜇伤处的红肿即让自身难受,又影响别人观感。
发明内容
[0006]本发明的目的之一是提供一种经济、有效、方便使用的快速消肿的外用药膏,该目的是通过以下技术方案实现的:
快速消肿的外用药膏,由按重量份计的下列原料制成:蒲公英20〜30重量份,大青叶I〜5重量份,瓜子金5〜15重量份,半边莲10〜20重量份,茶油100〜200重量份,蜂蜡30〜50
重量份.本发明有益效果在于:取材经济,所涉及的药材都是寻常药材,价格也便宜,方便广大工薪阶级人士自制使用;
对于蜜蜂蜇伤引起的红肿症状具有显著疗效;使用方便,使用时可以用纱布将本品包裹后敷于蜇伤处,三小时左右换一次药。
[0007]需要注意的是,本发明的药膏,禁止食用,且孕妇谨慎使用。
非蜜蜂蜇伤,重度的蜜蜂蜇伤也不适用。
[0008]
具体实施方式
[0009]以下通过具体实施例和实验例对本发明进行较为详细的说明。
[0010] 实施例1
按照下列重量份配取原料:
蒲公英25重量份,大青叶5重量份,瓜子金10重量份,半边莲15重量份,茶油150重量份,蜂錯30重量份。
[0011]将上述原料按照常规制法制成药膏。
[0012]本发明的快速消肿的外用药膏,经过民间20人次试验验证,总有效率达到95%,效果显著,下述为本发明I个具体实验例。
[0013] 实验例I
李某,女,被蜜蜂蛰伤后,肿了I天未消且有疼痛感;将本发明实施例1的药膏敷于患处,半天内红肿消除且疼痛感减轻,两天后痊愈。
Claims(1)
1.一种快速消肿的外用药膏,其特征在于,由按重量份计的下列原料制成:蒲公英20〜30重量份,大青叶I〜5重量份,瓜子金5〜15重量份,半边莲10〜20重量份,茶油100〜200重量份,蜂蜡30〜50重量份。
CN201610610865.9A
2016-07-29
2016-07-29
快速消肿的外用药膏
CN105963429A
(zh)
PriorityApplications(1)
ApplicationNumber
PriorityDate
FilingDate
Title
CN201610610865.9A
CN105963429A
(zh)
2016-07-29
2016-07-29
快速消肿的外用药膏
ApplicationsClaimingPriority(1)
ApplicationNumber
PriorityDate
FilingDate
Title
CN201610610865.9A
CN105963429A
(zh)
2016-07-29
2016-07-29
快速消肿的外用药膏
Publications(1)
PublicationNumber
PublicationDate
CN105963429A
true
CN105963429A
(zh)
2016-09-28
Family
ID=56951135
FamilyApplications(1)
ApplicationNumber
Title
PriorityDate
FilingDate
CN201610610865.9A
CN105963429A
(zh)
2016-07-29
2016-07-29
快速消肿的外用药膏
CountryStatus(1)
Country
Link
CN
(1)
CN105963429A
(zh)
Citations(6)
*Citedbyexaminer,†Citedbythirdparty
Publicationnumber
Prioritydate
Publicationdate
Assignee
Title
CN102961687A
(zh)
*
2012-12-05
2013-03-13
南通忠仁休闲用品有限公司
一种消肿止痛膏
CN103751295A
(zh)
*
2014-02-24
2014-04-30
万小耀
治疗肿痛的外用药物组合物、治疗肿痛的外用药油及其制作方法
CN104173410A
(zh)
*
2014-09-05
2014-12-03
南京泽朗生物科技有限公司
一种清热解毒膏
CN104257964A
(zh)
*
2014-09-25
2015-01-07
苏州市天灵中药饮片有限公司
一种活血化瘀膏及其制备方法
CN104906284A
(zh)
*
2015-05-27
2015-09-16
饶烨
一种消肿止痛膏及其制备方法
CN105327158A
(zh)
*
2014-08-13
2016-02-17
刘常春
一种消肿用中药组合物
2016
2016-07-29
CN
CN201610610865.9A
patent/CN105963429A/zh
active
Pending
PatentCitations(6)
*Citedbyexaminer,†Citedbythirdparty
Publicationnumber
Prioritydate
Publicationdate
Assignee
Title
CN102961687A
(zh)
*
2012-12-05
2013-03-13
南通忠仁休闲用品有限公司
一种消肿止痛膏
CN103751295A
(zh)
*
2014-02-24
2014-04-30
万小耀
治疗肿痛的外用药物组合物、治疗肿痛的外用药油及其制作方法
CN105327158A
(zh)
*
2014-08-13
2016-02-17
刘常春
一种消肿用中药组合物
CN104173410A
(zh)
*
2014-09-05
2014-12-03
南京泽朗生物科技有限公司
一种清热解毒膏
CN104257964A
(zh)
*
2014-09-25
2015-01-07
苏州市天灵中药饮片有限公司
一种活血化瘀膏及其制备方法
CN104906284A
(zh)
*
2015-05-27
2015-09-16
饶烨
一种消肿止痛膏及其制备方法
SimilarDocuments
Publication
PublicationDate
Title
CN104043068A
(zh)
2014-09-17
破解癌症的致病因素和中医治疗方法
CN103918926B
(zh)
2016-01-13
一种鸡饲料中药添加剂
CN104381557A
(zh)
2015-03-04
一种牛大力糖果制作方法
CN105639283A
(zh)
2016-06-08
一种辅助治疗癌症的富硒果蔬精华片的制备方法
CN109010587A
(zh)
2018-12-18
中药安神养生熏香及其制备方法
CN105285339B
(zh)
2019-01-08
一种饲料添加剂及制备方法
CN102552667B
(zh)
2013-08-14
一种用于调节人体免疫力的中药组合物
WO2014079395A1
(zh)
2014-05-30
一种可以提高免疫力的油类混合物
CN103751568B
(zh)
2016-10-05
一种治疗瘙痒症的中药组合物及其制备方法
CN107007646A
(zh)
2017-08-04
一种辅助防治癌症的营养复合物
CN106214758A
(zh)
2016-12-14
治疗蜜蜂蜇伤的外用药酒
CN105963428A
(zh)
2016-09-28
治疗蜜蜂蜇伤的外用药膏
CN105963429A
(zh)
2016-09-28
快速消肿的外用药膏
CN103893058A
(zh)
2014-07-02
一种中草药驱蚊水
CN104435126B
(zh)
2017-02-22
一种改善风湿痹痛、抗疲劳的中药制剂及其制备方法
CN106138443A
(zh)
2016-11-23
快速止痛的外用药膏
CN106074869A
(zh)
2016-11-09
具有退蜂刺功能的外用药膏
CN103816399B
(zh)
2016-06-08
一种用于治疗犬瘟热病的中药制剂
CN102260623A
(zh)
2011-11-30
解酒祛湿护肝保健酒及其制备方法
CN103923810A
(zh)
2014-07-16
一种养生保健酒
CN103845647A
(zh)
2014-06-11
一种治疗脾运失健型小儿厌食的中药
CN107970381A
(zh)
2018-05-01
一种化痰的宣木瓜茶及其制备方法和应用
CN106889272A
(zh)
2017-06-27
一种感冒凉茶及其制备方法
CN106860516A
(zh)
2017-06-20
一种杀灭牛皮肤寄生虫的中药药剂及其制备方法
CN107397746B
(zh)
2019-07-05
一种利用苦参碱治疗狐臭的中药提取物
LegalEvents
Date
Code
Title
Description
2016-09-28
C06
Publication
2016-09-28
PB01
Publication
2016-10-26
C10
Entryintosubstantiveexamination
2016-10-26
SE01
Entryintoforceofrequestforsubstantiveexamination
2020-01-10
WD01
Inventionpatentapplicationdeemedwithdrawnafterpublication
2020-01-10
WD01
Inventionpatentapplicationdeemedwithdrawnafterpublication
Applicationpublicationdate:
20160928
延伸文章資訊
- 1治療水腫的藥品列表 - A+醫學百科
用於高血壓病,心力衰竭,肝硬化等病以致水腫和腹水。 尿毒靈軟膏. 通腑泄濁,利尿消腫。用於全身浮腫、噁心嘔吐、大便不通、無尿少 ...
- 2德山消腫乳膏(新包裝) - 漁人藥業集團
- 3【消水腫藥膏】分享網路高手傳授祖傳消腫藥... +1 | 健康跟著走
消水腫藥膏:分享網路高手傳授祖傳消腫藥...,(照片為敷一次比照圖)分享網路高手傳授祖傳消腫藥膏簡單又有效敷有異狀就立刻拿起來適用於腫痛無皮膚外傷務必要先聽 ...
- 4水腫藥-新人首單立減十元-2022年3月|淘寶海外
當然來淘寶海外,淘寶當前有713件水腫藥相關的商品在售,其中按品牌劃分,有同仁堂13件、以嶺1 ... 老人消水腫去腳腫利尿劑臉部去浮水腫的藥痠麻腫痛消保健足貼神器.
- 5外用藥膏豆類消水腫 - 康健雜誌
找不到與關鍵字「外用藥膏豆類消水腫」相關的內容。 以下是您可能有興趣的內容,您也可以重新搜尋。 「三立海董」林崑海傳口腔癌逝,享壽68歲此疾病患者恐少活20年, ...